Vanguard Group Inc Cytokinetics Inc Put Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding CYTK
# of Institutions
406Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$772 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$428 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$395 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$345 Million0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.58MShares$241 Million29.98% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.96B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...